Author

Niels L.D. Ponse

Utrecht University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Assay:structural biology· 1

Frequent Co-Authors

Alvin X. HaniD· 2 shared Geert‐Jan BoonsiD· 2 shared Robert P. de VriesiD· 2 shared Alba Gabarroca GarcíaiD· 1 shared Annelies J. H. de Rooij· 1 shared Cindy M. SpruitiD· 1 shared Ding ZhangiD· 1 shared Elif UsluiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Alvin X. HanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The receptor binding properties of H5Nx influenza A viruses have evolved to promiscuously bind to avian-type mucin-like O-glycans

Julia Weber, Niels L.D. Ponse, Xueyong Zhu, María Ríos Carrasco, Alvin X. Han, Mathis Funk, Ting-Hui Lin, Alba Gabarroca García, Cindy M. Spruit, Ding Zhang, Wenli Yu, Ian A. Wilson, Mathilde Richard, Geert‐Jan Boons, Robert P. de Vries

This study identifies that H5Nx influenza A viruses bind promiscuously to avian-type mucin-like O-glycans, enhancing their zoonotic potential by binding human tracheal tissues.

PLoS Pathogens · Jan 20, 2026Peer-reviewedMicrobiology

Epistasis in the receptor binding domain of contemporary H3N2 viruses that reverted to bind sialylated diLacNAc repeats

Ruonan Liang, Francesca Peccati, Niels L.D. Ponse, Elif Uslu, Annelies J. H. de Rooij, Alvin X. Han, Geert‐Jan Boons, Luca Unione, Robert P. de Vries

This study identifies epistatic interactions in H3N2 influenza viruses that enable reversion to bind sialylated diLacNAc glycans, impacting receptor specificity and vaccine strain selection.

Cell Reports · Jul 17, 2025Peer-reviewedMicrobiology